SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_________________________________________________
FORM 8-K
_________________________________________________
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported):
January 8, 2021
_________________________________________________
SCIENTIFIC INDUSTRIES, INC.
_________________________________________________
(Exact
name of registrant as specified in its charter)
|
Delaware
|
|
000-6658
|
|
04-2217279
|
|
(State
or other Jurisdiction)
|
|
(Commission
File Number)
|
|
(IRS
Employer No.)
|
80 Orville Drive, Suite 102
Bohemia, New York 11716
__________________________________________________
(Address
of principal executive offices)
(631) 567-4700
__________________________________________________
(Registrant's
telephone number, including area code)
Not Applicable
__________________________________________________
(Former
name or former address, if changed since last report)
ITEM 1.01. ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT
The
Company and its wholly-owned subsidiary, Scientific Bioprocessing,
Inc., have agreed to an extension through December 31, 2021 of the
Monthly Retainer Agreement with Mr. Joseph G. Cremonese, a Director
of the Company since November 2002, and his affiliate, Laboratory Innovation Company,
Ltd. All other terms remain the same.
ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF
DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY
ARRANGEMENTS OF CERTAIN OFFICERS
On January 8, 2021, the Board accepted the resignation of Mr. John
F.F. Watkins as a Class C Director. Mr. Watkins’ resignation
was not the result of any dispute or disagreement with the Company.
The Company will pay Mr. Watkins director fees through December 31,
2020.
ITEM 9.01 Financial Statements and Exhibits
(a) and
(b) not applicable
(c)
Exhibits
|
Exhibit No.
|
|
Description
|
|
10.1
|
|
Amendment
to Monthly Retainer Agreement
|
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
|
|
SCIENTIFIC INDUSTRIES, INC.
|
|
|
|
|
|
|
|
|
|
|
|
Date: January 8, 2021
|
By:
|
/s/ Helena R. Santos_______________
|
|
|
|
|
Helena R. Santos,
|
|
|
|
|
President and Chief Executive Officer
|
|
|
|
|
|
|
January 8, 2021
Mr. Joseph G. Cremonese
PO Box 1907
Greensburg, PA 15601
Laboratory Innovation Company, Ltd.
PO Box 1907
Greensburg, PA 15601
Dear Joe:
Please confirm your agreement by signing where indicated below that
the term of your engagement and the engagement of Laboratory
Innovation Company, Ltd. (collectively, the
“Consultant”) pursuant to the Monthly Retainer
Agreement, dated as of January 1, 2020, as amended and/or extended
to date (the “Agreement”), with Scientific Bioprocessing, Inc. (the
“Company”), a wholly-owned subsidiary of Scientific
Industries, Inc., is hereby further extended to December 31, 2021,
subject to earlier termination by written notice by either the
Company or the Consultant delivered to the other party at least 60
days prior to the termination date set forth in the written
notice.
There are no other changes to the Agreement.
|
Scientific
Industries, Inc.
|
|
|
|
|
|
|
By:
|
/s/
Helena R. Santos
|
|
|
Helena
R. Santos
|
|
|
President
and CEO
|
|
Scientific
Bioprocessing, Inc.
|
|
|
|
|
|
|
By:
|
/s/
John A. Moore
|
|
|
John A.
Moore
|
|
|
President
|
Acknowledged
and agreed to:
|
Joseph
G. Cremonese
|
|
|
|
/s/
Joseph G. Cremonese
|
|
|
|
Laboratory
Innovations, Ltd.
|
|
|
|
|
|
|
By:
|
/s/
Joseph G. Cremonese
|
|
|
Joseph
G. Cremonese
|
|
|
President
|